Unknown

Dataset Information

0

Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients.

ABSTRACT:

SUBMITTER: Kaiser RA 

PROVIDER: S-EPMC8276570 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis.
| S-EPMC9053976 | biostudies-literature
Transcriptomics CITE-seq of 6 patients treated with the Pfizer BioNTech BNT162b2 mRNA vaccine
2021-06-25 | GSE171964 | GEO
Unknown Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines.
| S-EPMC8310186 | biostudies-literature
Unknown Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech.
| S-EPMC8514746 | biostudies-literature
Unknown Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients.
| S-EPMC8055922 | biostudies-literature
Unknown Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.
| S-EPMC8168345 | biostudies-literature
Unknown Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
| S-EPMC7556339 | biostudies-literature
Unknown Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection.
| S-EPMC8471735 | biostudies-literature
Unknown Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
| S-EPMC8607053 | biostudies-literature
Unknown Stability testing of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine: a translational study in UK vaccination centres.
| S-EPMC8647588 | biostudies-literature